Current healthcare decisions are designed for broad populations…much medicine is driven by a “one size fits all” approach, which results in excessive and inefficient spending. Liquid Biosciences has the only technology platform (based on 128+ trade secrets and patents) that can identify the biological and behavioral truth driving clinical outcomes. Liquid Biosciences provides predictive algorithms and biomarker discoveries, in exchange for economic participation in the creation of transformative value.